Delivery Order SPE2DB22D2214-SPE2DB25FS4CP
Award Date
3/7/25
Potential Completion Date
3/10/25
Potential Value
$1.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award, valued at $1,017.90, is for the delivery of Alfuzosin HCL ER 10 MG Tablets in 90-count packages. The contract has an ultimate completion date of December 19, 2024 and is a firm fixed-price delivery order. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award is for the delivery of Alfuzosin HCL ER 10 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $14,613.46, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a Firm Fixed Price Delivery Order with a completion date of March 7, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,644.03, is for the delivery of Alfuzosin HCL ER 10 mg tablets. This is a firm fixed price delivery order contract with an ultimate completion date of January 27, 2025. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,000.33 firm fixed-price delivery order is for the delivery of Alfuzosin HCL ER 10 mg tablets to support military healthcare programs. The contract has an ultimate completion date of July 12, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,413.12, is a delivery order for the supply of Alfuzosin HCL ER 10 mg tablets. The contract has an ultimate completion date of January 15, 2025 and is a firm fixed-price arrangement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, with ID SPE2DB24D1021|SPE2DB24FERQX, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,389.86, is for the delivery of Alfuzosin HCL ER 10 mg tablets. This is a firm fixed-price delivery order contract with a completion date of May 17, 2024. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the provision of Alfuzosin HCL ER 10 mg tablets. The delivery order, valued at $4,537.55, was issued under an Indefinite Delivery Contract (IDC) the company holds with the DLA Troop Support Medical. The IDC, valued at up to $999,999,999 through December 2025, enables the DLA to efficiently procure a comprehensive range of medical commodities, including pharmaceuticals, to support...
The Defense Logistics Agency (DLA) awarded a firm-fixed price delivery order valued at $2,506.72 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 120 tablets of Alfuzosin HCl ER 10 mg. This award is under Amerisourcebergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a ceiling value of up to $999,999,999 and is in effect through December 2025. The contract does not have a set-aside designation and is intended to support military...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,398.26, is for the delivery of Alfuzosin HCL ER 10 mg tablets over a period ending on October 20, 2023. This is a firm fixed-price delivery order contract, with no set-aside designation indicated. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,486.48 delivery order contract is for the supply of Alfuzosin HCL ER 10 mg tablets, and has a period of performance through October 2024. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen holds a larger $999,999,999 Indefinite...